Kenneth Y. Hartigan-Go, MD, MD

Kenneth Y. Hartigan-Go, MD, MD (UK)

Adjunct Faculty

EXPERTISE

Medicine, Health Systems and Governance, Pharmacovigilance

RESEARCH INTERESTS

Medicine Sciences and Health Systems, Toxicology, Regulatory Disciplines

Kenneth Y. Hartigan-Go, MD, MD (UK)

Adjunct Faculty

ACADEMIC BACKGROUND 

  • Doctor of Medicine, College of Medicine, University of the Philippines-Manila
  • Doctor of Medicine, University of Newcastle-upon-Tyne (UK)
  • Bachelor of Science, College of Arts and Sciences, University of the Philippines Diliman
  • Diplomate and Fellow, Internal Medicine, Philippine College of Physicians

PROFESSIONAL AND ACADEMIC EXPERIENCE

  • Undersecretary for Health Regulation, Department of Health
  • Chair, Research committee, Medicine Transparency Alliance Council of the Philippines (MeTA) (a project funded by UK)
  • Consultant to the Senate Committee on Health and Demographics
  • Regent, the Philippine College of Physicians (PCP)
  • Member of the UP Universal Health Care group of UP;   
  • Member of the Health Technology Assessment (HTA) Committee of the government’s National Health Insurance Program within the Philippine Health Insurance Corporation (PHIC), evaluating health technology and products, and advocating evidenced-based sound policy in the areas of financing, drug and medical procedure reimbursement
  • Coordinator for Secretary of Health, APEC Life Science Innovation Forum
  • Member, Bioethics Advisory Committee for Stem Cell Concerns
  • Elected as new board member, Asia Pacific Association of Medical Toxicologist (APAMT); Vice-Chair, National Quality Infrastructure  (under National Competitiveness Council); Member, Steering Committee of NUS Initiative to Promote Health in Asia (NIHA)
  • Member, WHO HQ Advisory Committee on the Safety of  Medicinal Products
  • Director IV, Department of Health-Food and Drug Administration; Health Scientist to National Committee of Biosafety of the Philippines
  • President, International Society For Pharmacoeconomics and Outcomes Research  (ISPOR), Philippines
  • Member, Formulary Executive Council
  • President of the Philippine Society of Experimental and Clinical Pharmacology
  • Convenor of the first Health Finance Summit co-organized the University 0f the Philippines, De La Salle University, Ateneo de Manila University and the Asian Institute of Management
  • Consultant to the EU- FP7 (Framework Project) Monitoring of Medicines work plan 1- 4
  • Consultant to the Chairman of the Committee on Health in the Philippine House of Representatives
  • Board of Trustees, the League of Corporate Foundations (LCF)
  • Member, WHO HQ Global Advisory Committee on Vaccine Safety
  • President, the Corporate Network for Disaster Response (CNDR)
  • Two – 3 year terms as Member of the Executive Committee of the International Society of Pharmacovigilance (ISoP) and Vice President on the last term
  • Resource Expert on Pharmaceutical Regulatory Science Network in APEC meetings
  • Former Member, Health Panel, Congressional Commission on Science, Technology and Engineering
  • Founding Executive Director, Zuellig Family Foundation
  • Member of technical committee, briefly served as Vice Chair of the Dangerous Drugs Board
  • Deputy Director, Bureau of Food and Drugs in Philippine Department of Health and, concurrently, Manager, National Drug Policy Program in Philippine Department of Health. In collaboration with Secretary of Health, crafted health sector reform agenda that created FOURmula One for Health that in 2005 became the guiding implementation framework for health sector reforms.
  • Founder, Adverse Drug Reaction Monitoring Program for the Philippine Government in partnership with Australian Assistance for International Development.  Served as Project Leader, Adverse Drug Reaction Monitoring Programme  and Vice-Chairman, National Adverse Drug Reaction Advisory Committee (DOH-NDP-AusAID Cooperation)
  • Founding Member and Country Director, Association of Medical Doctors for Asia

    AFFILIATIONS, AWARDS AND HONORS

    • Fellow of the American College of Physicians
    • Fellow of the Royal College of Physicians (Edinburgh)
    • Fellow, Institute of Corporate Directors
    • UP Reserve Officers Training Corp program: Honor Sword, two Honor Star medals, Leadership medal (1978-1981)
    • Philippine Board Certified Internist, Philippine College of Physicians, 1992
    • Medicine, Board of Medicine, Professional Regulation Commission, 1986
    • The Drug Information Association Outstanding Service Award, USA (2001)
    • Distinguished Fellow Award from the Philippine College of Physicians (2008)
    • Recipient of Dr. Jose P. Rizal Award for Excellence as Outstanding Chinese Filipino in the field of Medicine, The Manila Times (2008)
    • Outstanding Graduate Award, ROTC, Armed Forces of the Philippines (2012)

    PUBLICATIONS

    • Bate, A., Beckmann, J., Dodoo, A., Härmark, L., Hartigan-Go, K., Hegerius, A., . . . Hagemann, U. (2017). Developing a Crowdsourcing Approach and Tool for Pharmacovigilance Education Material Delivery. Drug Safety, 40(3), 191-199. doi:10.1007/s40264-016-0495-9
    • Edwin J. Asturias, Melinda Wharton, Robert Pless, Noni E. MacDonald, Robert T. Chen, Nicholas Andrew, David Salisbury, Alexander N. Dodoo, Kenneth Hartigan-Go, Patrick L.F. Zuber. “Contributions and challenges for worldwide vaccine safety: The Global Advisory Committee on Vaccine Safety at 15 years”. Vaccine 34 (2016), pp. 3342-3349
    • Beckmann J, Hartigan-Go K, et.al. “Teaching Pharmacovigilance: the WHO-ISop Core Elements of a Comprehensive Modular 37: 743-759 Drug Safety